Requirements for human medical genome testing utilising massively parallel sequencing technologies (First Edition 2017)
This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA) Scheme and supporting the development of the Pathology Standards.
Requirements for human medical genome testing utilising massively parallel sequencing technologies (First Edition 2017) is currently in use.
This Standard outlines the minimum best practice requirements for medical pathology laboratories undertaking human genetic testing using massively parallel sequencing technologies, including single gene, gene panel, somatic, whole exome, whole genome and non-invasive prenatal screening applications.
| The Commission is undergoing a review process for each of the Pathology Standards. To stay informed about upcoming consultations and provide input, please sign up for ongoing updates. You can also read the latest in pathology news. |
For more information about the NPA scheme please visit National Pathology Accreditation Scheme or email the Pathology Standards team.
Downloads
Requirements for human medical genome testing utilising massively parallel sequencing technologies (First Edition 2017)
- For more information:
- Pathology Standards
- Publication Year:
- 2022
- Resource Type:
- Standard
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.